B16-F10, also referred to as AC-370 cell line, is a murine melanoma cell line. This is established from a B16 melanoma tumor grown in syngeneic C57BL/6 mice. 

In addition, doxorubicin-resistant line of B16 melanoma (B16VDXR) was obtained in vitro by continuous exposure to increasing concentrations of doxorubicin of an in vitro line (B16V) derived from the in vivo transplanted B16 melanoma.

https://www.dsmz.de/catalogues/details/culture/ACC-370.html

Article In vivo characterization of a doxorubicin resistant B16 mela...

Article Characterization of a doxorubicin-resistant murine melanoma ...

I beg to differ from the previous answer. B16-F10 is not "AC-370" (probably meant ACC-370). 

DSMZ distributes B16V the parent line of B16VDXR as ACC-370, see:

http://web.expasy.org/cellosaurus/CVCL_1950

But B16-F10 is another derivative of B16 and is not distributed by DSMZ but by ATCC. See:

http://web.expasy.org/cellosaurus/CVCL_0159

In fact the descendent tree of the B16 melanoma cell lines is quite complex and can be represented as such:

HFH-18

  B16 (=B16 subline B78)

    B16 melanoma 4A5

    B16-A

    B16-B

    B78H1

    B16V

      B16VDXR

    B16-F0

       B16-F1

          B16-F10

             B16-BL6

If you start from the parent line:

http://web.expasy.org/cellosaurus/CVCL_GS32

You can follow the different children lineage.

Thank you both for these presisions. Would there be in your view any reason to choose B16V over B16-F10 cells to generate a cancer model via subcutenous injection?